In the United States, it is estimated that seven percent of the adult population suffers from complications associated with diabetes, many of which are associated with complications of Type 2 diabetes. Also commonly referred to as adult-onset diabetes, individuals who suffer from this blood glucose complication find their quality life is significantly deteriorated as the condition is unmanageable by diet and exercise.
In an effort to remedy the significant number of under treated Americans who suffer from Type 2 diabetes, King Pharmaceuticals has release an FDA approved drug known as Glumetza. As a drug that boasts achievement in managing Type 2 diabetes alone or in combination with insulin therapy.
Glumetza, as a twice-per-day dosing formula, is recommended in dosing of 500 milligrams or, as a once-per-day dosing, at 850 milligrams. However, if you plan to use Glumetza in combination with insulin therapy, your healthcare professional should begin with once-per-day dosing of 500 milligrams, with 500 milligram increases as needed.
As with any FDA approved drug, the use of Glumetza, in the treatment of Type 2 diabetes, as a sole form of treatment or as a combination therapy, does not come without side effects. Side effects most commonly reported by patients include too low blood sugar, known as hypoglycemia, lethargy, diarrhea and nausea. While some patients report a resolution of symptoms with treatment, others report complications are not alleviated and, in rare cases, may discontinue the use of Glumetza.
Additionally, as a Category B drug classification, the use of Glumetza may be safe for use in pregnancy however careful consideration should be made with management of Type 2 diabetes attempted by diet and exercise first. Therefore, if you are a woman who is pregnant, or may become pregnant, be certain your doctor is familiar with your family planning decisions when considering treatment options for Type 2 diabetes.
For patients who suffer from pre-existing, or co morbid, complications involving cardiovascular disease or kidney complications, the use of Glumetza may not be indicated in Type 2 diabetes. Additionally, if you have a history of vitamin B12 deficiency, or anemia, it is important to manage B12 supplementation while using Glumetza to treat Type 2 diabetes.
As with any blood glucose complication, the key to your successful management of diabetic symptoms may lie in the early diagnosis and treatment. When suffering from Type 2 diabetes, and under the management of the condition with insulin therapy, it is important to discuss the use of Glumetza with your health professional to ensure every consideration is made in providing optimal medication management of your diabetic condition.